Zippa biotech

High-technology enterprises, teams of professionals, corporate chain-wide health services platform

Under the leadership of the core team of prof. Yoon seon ping, a high-tech enterprise for the development, market application, health management and integration of genetics technology was established at zippa biotechnology ltd. It aims to create an accurate, integrated, systematic, individualized, branded, industry-wide health service platform。

Focus on client experience, keeping pace with market demand, multiple services

It adheres to the core concept of "technology for social development" and has always been based on client experience and market demand for research and development. Services such as screening for diseases, genetic testing of children's talents, screening of children's health, guidance on safe medicine, accurate prevention, and online consultations are carried out on the basis of the needs of human health, so that biotechnology actually enters the country's home for the benefit of the general public。

Health problems are not positive. Cancer endangers the lives of people in the country

Data from the cancer centre shutdown show that every year we have more than 3. 5 million new cancers, more than 2 million deaths, and that lung, breast and stomach cancers are common. Cancer control is difficult and burdened, and has become one of the major public health problems that seriously endangers human health. Studies show that our overall cancer survival rate is around 30 per cent for five years and that there is still a significant gap in the more developed countries。